The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer Article

Rosen, Barry, Laframboise, Stephane, Ferguson, Sarah et al. (2014). The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer . GYNECOLOGIC ONCOLOGY, 134(3), 462-467. 10.1016/j.ygyno.2014.07.004

cited authors

  • Rosen, Barry; Laframboise, Stephane; Ferguson, Sarah; Dodge, Jason; Bernardini, Marcus; Murphy, Joan; Segev, Yakir; Sun, Ping; Narod, Steven A

sustainable development goals

authors

publication date

  • September 1, 2014

published in

keywords

  • ADVANCED-STAGE OVARIAN
  • CISPLATIN
  • CYTOREDUCTION
  • GYNECOLOGIC-ONCOLOGY-GROUP
  • Intraperitoneal chemotherapy
  • Life Sciences & Biomedicine
  • Neoadjuvant chemotherapy
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • PACLITAXEL
  • PHASE-III TRIAL
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 462

end page

  • 467

volume

  • 134

issue

  • 3